Trust is no longer enough: secure data sharing requires international collaboration across institutions and governments.

AI has great potential to spur progress in genomic medicine, but institutions face a few challenges in using it responsibly.

GSK is one of the first to lead a further expansion of 50,000 whole genomes paired with proteomic data The AGD dataset is among the largest collections of whole genome sequences available, and it is ...

NashBio, a pioneer in genomics and real-world data, is transforming life sciences research by making complex healthcare data more accessible. Co-founded by Leeland Ekstrom, NashBio leverages ...

A major European survey marks a significant milestone in the effort to control antimicrobial resistance (AMR), providing the ...

Genomic data provides evidence for a previously unknown wave of migration, with Indigenous groups living in central and ...

From the earliest days of the pandemic that shocked the world in 2020, researchers at Fred Hutch Cancer Center tracked the rapid evolution and spread of the virus that causes COVID-19 by studying how ...

The permanent, personal data is some of the most sensitive that the government handles due to the national security risks. The National Institutes of Health and other agencies tasked with protecting ...

A MAJOR genomic study has uncovered dozens of new genetic signals linked to endometriosis, offering fresh insight into the ...

Differences in the physical shape and wiring of the brain can directly contribute to the development of attention and social ...

Dataset grows to more than 312,000 whole genomes with longitudinal clinical data GSK is one of the first to lead a further expansion of 50,000 whole genomes paired with proteomic data The AGD dataset ...